Strs Ohio Eloxx Pharmaceuticals, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$3.02 - $4.54 $9,362 - $14,074	-3,100 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$8.77 - $12.49 $28,064 - $39,968	-3,200 Reduced 50.79%	3,100 $30,000
Q2 2018 Aug 06, 2018	BUY	$8.75 - $23.27 $55,125 - $146,601	6,300 New	6,300 $107,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.